![](https://ml.globenewswire.com/media/209d26d1-815f-4a6c-bbc5-7da03514a8b2/small/adct-logo-jpg.jpg)
ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering
LAUSANNE, Switzerland, April 24, 2020 (GLOBE NEWSWIRE) -- ADC Therapeutics SA, a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent and targeted antibody drug conjugates for patients …